Asia-Pacific MAb Biosimilars Market Report 2017

Table of Contents

Asia-Pacific MAb Biosimilars Market Report 2017
1 MAb Biosimilars Overview
1.1 Product Overview and Scope of MAb Biosimilars
1.2 Classification of MAb Biosimilars by Product Category
1.2.1 Asia-Pacific MAb Biosimilars Market Size (Sales) Comparison by Types (2012-2022)
1.2.2 Asia-Pacific MAb Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Synthetic chemicls
1.2.4 Biopharmaceuticals
1.2.5 Others
1.3 Asia-Pacific MAb Biosimilars Market by Application/End Users
1.3.1 Asia-Pacific MAb Biosimilars Sales (Volume) and Market Share Comparison by Applications (2012-2022)
1.3.2 Chronic and autoimmune diseases
1.3.3 Oncology
1.4 Asia-Pacific MAb Biosimilars Market by Region
1.4.1 Asia-Pacific MAb Biosimilars Market Size (Value) Comparison by Region (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Japan Status and Prospect (2012-2022)
1.4.4 South Korea Status and Prospect (2012-2022)
1.4.5 Taiwan Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.4.7 Southeast Asia Status and Prospect (2012-2022)
1.4.8 Australia Status and Prospect (2012-2022)
1.5 Asia-Pacific Market Size (Value and Volume) of MAb Biosimilars (2012-2022)
1.5.1 Asia-Pacific MAb Biosimilars Sales and Growth Rate (2012-2022)
1.5.2 Asia-Pacific MAb Biosimilars Revenue and Growth Rate (2012-2022)

2 Asia-Pacific MAb Biosimilars Competition by Players/Suppliers, Region, Type and Application
2.1 Asia-Pacific MAb Biosimilars Market Competition by Players/Suppliers
2.1.1 Asia-Pacific MAb Biosimilars Sales Volume and Market Share of Key Players/Suppliers (2012-2017)
2.1.2 Asia-Pacific MAb Biosimilars Revenue and Share by Players/Suppliers (2012-2017)
2.2 Asia-Pacific MAb Biosimilars (Volume and Value) by Type
2.2.1 Asia-Pacific MAb Biosimilars Sales and Market Share by Type (2012-2017)
2.2.2 Asia-Pacific MAb Biosimilars Revenue and Market Share by Type (2012-2017)
2.3 Asia-Pacific MAb Biosimilars (Volume) by Application
2.4 Asia-Pacific MAb Biosimilars (Volume and Value) by Region
2.4.1 Asia-Pacific MAb Biosimilars Sales and Market Share by Region (2012-2017)
2.4.2 Asia-Pacific MAb Biosimilars Revenue and Market Share by Region (2012-2017)

3 China MAb Biosimilars (Volume, Value and Sales Price)
3.1 China MAb Biosimilars Sales and Value (2012-2017)
3.1.1 China MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
3.1.2 China MAb Biosimilars Revenue and Growth Rate (2012-2017)
3.1.3 China MAb Biosimilars Sales Price Trend (2012-2017)
3.2 China MAb Biosimilars Sales Volume and Market Share by Type
3.3 China MAb Biosimilars Sales Volume and Market Share by Application

4 Japan MAb Biosimilars (Volume, Value and Sales Price)
4.1 Japan MAb Biosimilars Sales and Value (2012-2017)
4.1.1 Japan MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
4.1.2 Japan MAb Biosimilars Revenue and Growth Rate (2012-2017)
4.1.3 Japan MAb Biosimilars Sales Price Trend (2012-2017)
4.2 Japan MAb Biosimilars Sales Volume and Market Share by Type
4.3 Japan MAb Biosimilars Sales Volume and Market Share by Application

5 South Korea MAb Biosimilars (Volume, Value and Sales Price)
5.1 South Korea MAb Biosimilars Sales and Value (2012-2017)
5.1.1 South Korea MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
5.1.2 South Korea MAb Biosimilars Revenue and Growth Rate (2012-2017)
5.1.3 South Korea MAb Biosimilars Sales Price Trend (2012-2017)
5.2 South Korea MAb Biosimilars Sales Volume and Market Share by Type
5.3 South Korea MAb Biosimilars Sales Volume and Market Share by Application

6 Taiwan MAb Biosimilars (Volume, Value and Sales Price)
6.1 Taiwan MAb Biosimilars Sales and Value (2012-2017)
6.1.1 Taiwan MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
6.1.2 Taiwan MAb Biosimilars Revenue and Growth Rate (2012-2017)
6.1.3 Taiwan MAb Biosimilars Sales Price Trend (2012-2017)
6.2 Taiwan MAb Biosimilars Sales Volume and Market Share by Type
6.3 Taiwan MAb Biosimilars Sales Volume and Market Share by Application

7 India MAb Biosimilars (Volume, Value and Sales Price)
7.1 India MAb Biosimilars Sales and Value (2012-2017)
7.1.1 India MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
7.1.2 India MAb Biosimilars Revenue and Growth Rate (2012-2017)
7.1.3 India MAb Biosimilars Sales Price Trend (2012-2017)
7.2 India MAb Biosimilars Sales Volume and Market Share by Type
7.3 India MAb Biosimilars Sales Volume and Market Share by Application

8 Southeast Asia MAb Biosimilars (Volume, Value and Sales Price)
8.1 Southeast Asia MAb Biosimilars Sales and Value (2012-2017)
8.1.1 Southeast Asia MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
8.1.2 Southeast Asia MAb Biosimilars Revenue and Growth Rate (2012-2017)
8.1.3 Southeast Asia MAb Biosimilars Sales Price Trend (2012-2017)
8.2 Southeast Asia MAb Biosimilars Sales Volume and Market Share by Type
8.3 Southeast Asia MAb Biosimilars Sales Volume and Market Share by Application

9 Australia MAb Biosimilars (Volume, Value and Sales Price)
9.1 Australia MAb Biosimilars Sales and Value (2012-2017)
9.1.1 Australia MAb Biosimilars Sales Volume and Growth Rate (2012-2017)
9.1.2 Australia MAb Biosimilars Revenue and Growth Rate (2012-2017)
9.1.3 Australia MAb Biosimilars Sales Price Trend (2012-2017)
9.2 Australia MAb Biosimilars Sales Volume and Market Share by Type
9.3 Australia MAb Biosimilars Sales Volume and Market Share by Application

10 Asia-Pacific MAb Biosimilars Players/Suppliers Profiles and Sales Data
10.1 Biocon
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 MAb Biosimilars Product Category, Application and Specification
10.1.2.1 Product A
10.1.2.2 Product B
10.1.3 Biocon MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.1.4 Main Business/Business Overview
10.2 Celltrion
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 MAb Biosimilars Product Category, Application and Specification
10.2.2.1 Product A
10.2.2.2 Product B
10.2.3 Celltrion MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.2.4 Main Business/Business Overview
10.3 Dr. Reddy's Laboratories
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 MAb Biosimilars Product Category, Application and Specification
10.3.2.1 Product A
10.3.2.2 Product B
10.3.3 Dr. Reddy's Laboratories MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.3.4 Main Business/Business Overview
10.4 Hospira
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 MAb Biosimilars Product Category, Application and Specification
10.4.2.1 Product A
10.4.2.2 Product B
10.4.3 Hospira MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.4.4 Main Business/Business Overview
10.5 3SBio
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 MAb Biosimilars Product Category, Application and Specification
10.5.2.1 Product A
10.5.2.2 Product B
10.5.3 3SBio MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.5.4 Main Business/Business Overview
10.6 Accord Healthcare
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 MAb Biosimilars Product Category, Application and Specification
10.6.2.1 Product A
10.6.2.2 Product B
10.6.3 Accord Healthcare MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.6.4 Main Business/Business Overview
10.7 AET Biotech
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 MAb Biosimilars Product Category, Application and Specification
10.7.2.1 Product A
10.7.2.2 Product B
10.7.3 AET Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.7.4 Main Business/Business Overview
10.8 Allergan
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 MAb Biosimilars Product Category, Application and Specification
10.8.2.1 Product A
10.8.2.2 Product B
10.8.3 Allergan MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.8.4 Main Business/Business Overview
10.9 Alvartis Pharma
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 MAb Biosimilars Product Category, Application and Specification
10.9.2.1 Product A
10.9.2.2 Product B
10.9.3 Alvartis Pharma MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.9.4 Main Business/Business Overview
10.10 Amega Biotech
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 MAb Biosimilars Product Category, Application and Specification
10.10.2.1 Product A
10.10.2.2 Product B
10.10.3 Amega Biotech MAb Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
10.10.4 Main Business/Business Overview
10.11 Amgen
10.12 Apotex
10.13 BioXpress Therapeutics
10.14 Natco Pharma
10.15 Sanifo
10.16 Synthon

11 MAb Biosimilars Manufacturing Cost Analysis
11.1 MAb Biosimilars Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of MAb Biosimilars

12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 MAb Biosimilars Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of MAb Biosimilars Major Manufacturers in 2016
12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 Distributors/Traders List

14 Market Effect Factors Analysis
14.1 Technology Progress/Risk
14.1.1 Substitutes Threat
14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 Asia-Pacific MAb Biosimilars Market Forecast (2017-2022)
15.1 Asia-Pacific MAb Biosimilars Sales Volume, Revenue and Price Forecast (2017-2022)
15.1.1 Asia-Pacific MAb Biosimilars Sales Volume and Growth Rate Forecast (2017-2022)
15.1.2 Asia-Pacific MAb Biosimilars Revenue and Growth Rate Forecast (2017-2022)
15.1.3 Asia-Pacific MAb Biosimilars Price and Trend Forecast (2017-2022)
15.2 Asia-Pacific MAb Biosimilars Sales Volume, Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.1 Asia-Pacific MAb Biosimilars Sales Volume and Growth Rate Forecast by Region (2017-2022)
15.2.2 Asia-Pacific MAb Biosimilars Revenue and Growth Rate Forecast by Region (2017-2022)
15.2.3 China MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.4 Japan MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.5 South Korea MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.6 Taiwan MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.7 India MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.8 Southeast Asia MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
15.2.9 Australia MAb Biosimilars Sales, Revenue and Growth Rate Forecast (2017-2022)
15.3 Asia-Pacific MAb Biosimilars Sales, Revenue and Price Forecast by Type (2017-2022)
15.3.1 Asia-Pacific MAb Biosimilars Sales Forecast by Type (2017-2022)
15.3.2 Asia-Pacific MAb Biosimilars Revenue Forecast by Type (2017-2022)
15.3.3 Asia-Pacific MAb Biosimilars Price Forecast by Type (2017-2022)
15.4 Asia-Pacific MAb Biosimilars Sales Forecast by Application (2017-2022)

16 Research Findings and Conclusion

17 Appendix
17.1 Methodology/Research Approach
17.1.1 Research Programs/Design
17.1.2 Market Size Estimation
17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
17.2.1 Secondary Sources
17.2.2 Primary Sources
17.3 Disclaimer

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.